Matrix Metalloproteinases in Inflammatory Bowel Disease - From Basic Research to Clinical Significance

被引:9
|
作者
Rath, T. [1 ]
Roderfeld, M. [1 ]
Graf, J. [2 ]
Roeb, E. [1 ]
机构
[1] Univ Giessen, Zentrum Innere Med, D-35385 Giessen, Germany
[2] Univ Marburg, D-35032 Marburg, Germany
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2009年 / 47卷 / 08期
关键词
ulcerative colitis; Crohn's disease; chronic inflammatory bowel disease; matrix metalloproteinases; TIMP; RHEUMATOID SYNOVIAL FIBROBLASTS; NECROSIS-FACTOR-ALPHA; HEMOPEXIN-LIKE DOMAIN; SMOOTH-MUSCLE-CELLS; GELATINASE-A MMP-2; TISSUE INHIBITOR; EXTRACELLULAR-MATRIX; CROHNS-DISEASE; ULCERATIVE-COLITIS; GENE-EXPRESSION;
D O I
10.1055/s-0028-1109520
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Matrix Metalloproteinases (MMPs) are a family of Zn2+-dependent endopeptidases that are considered to be the most potent proteases in the turnover of the extracellular matrix (ECM). In addition to their capability for degradating virtually all protein components of the ECM, MMPs regulate a variety of non-matrix substrates such as chemokines, cytokines and growth factors. Therefore MMPs play a central role in a variety of physiological and pathological processes such as angiogenesis, wound healing and inflammatory response including mucosal inflammation associated with inflammatory bowel disease (IBD). Apart from mucosal destruction in IBD, recent studies have identified several new functions of MMPs for the pathophysiology of the healthy and inflamed intestine. This article summarises the main activities of MMPs in IBD with emphasis on their pathophysiological relevance and potential clinical implications based on the expression and regulation patterns of these enzymes.
引用
收藏
页码:758 / 769
页数:12
相关论文
共 50 条
  • [41] Clinical significance of the glucose breath test in patients with inflammatory bowel disease
    Lee, Ji Min
    Lee, Kang-Moon
    Chung, Yoon Yung
    Lee, Yang Woon
    Kim, Dae Bum
    Sung, Hea Jung
    Chung, Woo Chul
    Paik, Chang-Nyol
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (06) : 990 - 994
  • [42] CLINICAL SIGNIFICANCE OF URINARY GLYCOSAMINOGLYCAN EXCRETION IN INFLAMMATORY BOWEL DISEASE PATIENTS
    Derkacz, A.
    Olczyk, P.
    Jura-Poltorak, A.
    Waluga-Kozlowska, E.
    Olczyk, K.
    Komosinska-Vassev, K.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 71 (06): : 1 - 9
  • [43] Hyperamylasemia in inflammatory bowel disease: prevalence and clinical significance in a referral centre
    Zois, Christos
    Katsanos, Konstantinos
    Vagias, Ioannis
    Tsianos, Vasileios
    Christodoulou, Dimitrios
    Tsianos, Epameinondas
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 : 83 - 83
  • [44] Clinical significance of low transaminase levels in children with inflammatory bowel disease
    Murat Cakir
    Elif Sag
    Guzide Dogan
    Fatih Unal
    Erhun Kasirga
    World Journal of Pediatrics, 2019, 15 : 143 - 147
  • [45] Endoscopic activity in inflammatory bowel disease: clinical significance and application in practice
    Kim, Kyeong Ok
    CLINICAL ENDOSCOPY, 2022, 55 (04) : 480 - 488
  • [46] The significance of pANCA in inflammatory bowel disease
    Radford-Smith, GL
    Bansal, A
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 (09) : 863 - 864
  • [47] MicroRNA in inflammatory bowel disease: Translational research and clinical implication
    Fisher, Kurt
    Lin, Jingmei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (43) : 12274 - 12282
  • [48] Effects of curcumin and Ginkgo biloba on matrix metalloproteinases gene expression and other biomarkers of inflammatory bowel disease
    Tarek Kamal Motawi
    Sherine Maher Rizk
    Ahmed Hassan Shehata
    Journal of Physiology and Biochemistry, 2012, 68 : 529 - 539
  • [49] Effects of curcumin and Ginkgo biloba on matrix metalloproteinases gene expression and other biomarkers of inflammatory bowel disease
    Motawi, Tarek Kamal
    Rizk, Sherine Maher
    Shehata, Ahmed Hassan
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2012, 68 (04) : 529 - 539
  • [50] The effect of an inhibitor of matrix metalloproteinases an colonic inflammation in a trinitrobenzenesulphonic acid rat model of inflammatory bowel disease
    Sykes, AP
    Bhogal, R
    Brampton, C
    Chander, C
    Whelan, C
    Parsons, ME
    Bird, J
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (11) : 1535 - 1542